Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA

The spirochete strains that cause Lyme disease are different between the USA and Europe. This leads not only to a variation in clinical presentations, but it was also thought to alter responsiveness to antibiotic treatment. Unlike in Europe, in the USA there are no head-to-head trials of oral and in...

Full description

Saved in:
Bibliographic Details
Published in:Oxford Medical Case Reports 2014-12, Vol.2014 (9), p.162-163
Main Authors: Jassam, Yasir N, Thaler, David E
Format: Article
Language:English
Subjects:
Case Reports
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583
cites cdi_FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583
container_end_page 163
container_issue 9
container_start_page 162
container_title Oxford Medical Case Reports
container_volume 2014
creator Jassam, Yasir N
Thaler, David E
description The spirochete strains that cause Lyme disease are different between the USA and Europe. This leads not only to a variation in clinical presentations, but it was also thought to alter responsiveness to antibiotic treatment. Unlike in Europe, in the USA there are no head-to-head trials of oral and intravenous antibiotics in the treatment of neuroborreliosis. Guidelines from the American Academy of Neurology (AAN) state that oral doxycycline is probably safe and effective in treating neuroborrliosis without parenchymal involvement, this was mainly extrapolated from European studies data with no reports from North America. To the best of our knowledge, this is the first reported case of Lyme meningo-radiculitis successfully treated with oral doxycycline alone in the USA. This comes in support of the oral doxycycline as an initial and even monotherapy for non-parenchymal Lyme disease of the nervous system in the USA.
doi_str_mv 10.1093/omcr/omu061
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4370023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25988066</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhiMEYtPYiTvqHRWcpEmzC9I08alJHGDnKE3dLahtpmSb6L-n02AaF9uyX7-2HkKuKdxRmPB739jQhy1IekaGDARPlRLi_KQekHGMXwBAuaRcqUsyYGKiFEg5JG_zrsGkwda1S58GUzq7rd3GxSRgXPs2uh0mG5_4YOqk9N-d7Wzt2r63wmDWXeLafZksPqZX5KIydcTxbx6RxdPj5-wlnb8_v86m89QyyWmKTEIORSWZkaVCqxgzOVqsMiULCUzlZYZUUFvRUtDMSFVQISYUKsxyFIqPyMPBd70tGiwttpv-Ob0OrjGh0944_X_SupVe-p3OeA7AeG9wezCwwccYsDruUtB7qnpPVR-o9uqb03NH7R9D_gPZMXX5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA</title><source>PubMed Central Free</source><source>Oxford Open</source><creator>Jassam, Yasir N ; Thaler, David E</creator><creatorcontrib>Jassam, Yasir N ; Thaler, David E</creatorcontrib><description>The spirochete strains that cause Lyme disease are different between the USA and Europe. This leads not only to a variation in clinical presentations, but it was also thought to alter responsiveness to antibiotic treatment. Unlike in Europe, in the USA there are no head-to-head trials of oral and intravenous antibiotics in the treatment of neuroborreliosis. Guidelines from the American Academy of Neurology (AAN) state that oral doxycycline is probably safe and effective in treating neuroborrliosis without parenchymal involvement, this was mainly extrapolated from European studies data with no reports from North America. To the best of our knowledge, this is the first reported case of Lyme meningo-radiculitis successfully treated with oral doxycycline alone in the USA. This comes in support of the oral doxycycline as an initial and even monotherapy for non-parenchymal Lyme disease of the nervous system in the USA.</description><identifier>ISSN: 2053-8855</identifier><identifier>EISSN: 2053-8855</identifier><identifier>DOI: 10.1093/omcr/omu061</identifier><identifier>PMID: 25988066</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Case Reports</subject><ispartof>Oxford Medical Case Reports, 2014-12, Vol.2014 (9), p.162-163</ispartof><rights>The Author 2014. Published by Oxford University Press. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583</citedby><cites>FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370023/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370023/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25988066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jassam, Yasir N</creatorcontrib><creatorcontrib>Thaler, David E</creatorcontrib><title>Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA</title><title>Oxford Medical Case Reports</title><addtitle>Oxf Med Case Reports</addtitle><description>The spirochete strains that cause Lyme disease are different between the USA and Europe. This leads not only to a variation in clinical presentations, but it was also thought to alter responsiveness to antibiotic treatment. Unlike in Europe, in the USA there are no head-to-head trials of oral and intravenous antibiotics in the treatment of neuroborreliosis. Guidelines from the American Academy of Neurology (AAN) state that oral doxycycline is probably safe and effective in treating neuroborrliosis without parenchymal involvement, this was mainly extrapolated from European studies data with no reports from North America. To the best of our knowledge, this is the first reported case of Lyme meningo-radiculitis successfully treated with oral doxycycline alone in the USA. This comes in support of the oral doxycycline as an initial and even monotherapy for non-parenchymal Lyme disease of the nervous system in the USA.</description><subject>Case Reports</subject><issn>2053-8855</issn><issn>2053-8855</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhiMEYtPYiTvqHRWcpEmzC9I08alJHGDnKE3dLahtpmSb6L-n02AaF9uyX7-2HkKuKdxRmPB739jQhy1IekaGDARPlRLi_KQekHGMXwBAuaRcqUsyYGKiFEg5JG_zrsGkwda1S58GUzq7rd3GxSRgXPs2uh0mG5_4YOqk9N-d7Wzt2r63wmDWXeLafZksPqZX5KIydcTxbx6RxdPj5-wlnb8_v86m89QyyWmKTEIORSWZkaVCqxgzOVqsMiULCUzlZYZUUFvRUtDMSFVQISYUKsxyFIqPyMPBd70tGiwttpv-Ob0OrjGh0944_X_SupVe-p3OeA7AeG9wezCwwccYsDruUtB7qnpPVR-o9uqb03NH7R9D_gPZMXX5</recordid><startdate>20141229</startdate><enddate>20141229</enddate><creator>Jassam, Yasir N</creator><creator>Thaler, David E</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20141229</creationdate><title>Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA</title><author>Jassam, Yasir N ; Thaler, David E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Case Reports</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jassam, Yasir N</creatorcontrib><creatorcontrib>Thaler, David E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxford Medical Case Reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jassam, Yasir N</au><au>Thaler, David E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA</atitle><jtitle>Oxford Medical Case Reports</jtitle><addtitle>Oxf Med Case Reports</addtitle><date>2014-12-29</date><risdate>2014</risdate><volume>2014</volume><issue>9</issue><spage>162</spage><epage>163</epage><pages>162-163</pages><issn>2053-8855</issn><eissn>2053-8855</eissn><abstract>The spirochete strains that cause Lyme disease are different between the USA and Europe. This leads not only to a variation in clinical presentations, but it was also thought to alter responsiveness to antibiotic treatment. Unlike in Europe, in the USA there are no head-to-head trials of oral and intravenous antibiotics in the treatment of neuroborreliosis. Guidelines from the American Academy of Neurology (AAN) state that oral doxycycline is probably safe and effective in treating neuroborrliosis without parenchymal involvement, this was mainly extrapolated from European studies data with no reports from North America. To the best of our knowledge, this is the first reported case of Lyme meningo-radiculitis successfully treated with oral doxycycline alone in the USA. This comes in support of the oral doxycycline as an initial and even monotherapy for non-parenchymal Lyme disease of the nervous system in the USA.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>25988066</pmid><doi>10.1093/omcr/omu061</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2053-8855
ispartof Oxford Medical Case Reports, 2014-12, Vol.2014 (9), p.162-163
issn 2053-8855
2053-8855
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4370023
source PubMed Central Free; Oxford Open
subjects Case Reports
title Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A25%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lyme%20meningo-radiculitis%20responsive%20to%20oral%20doxycycline%20therapy%20in%20the%20USA&rft.jtitle=Oxford%20Medical%20Case%20Reports&rft.au=Jassam,%20Yasir%20N&rft.date=2014-12-29&rft.volume=2014&rft.issue=9&rft.spage=162&rft.epage=163&rft.pages=162-163&rft.issn=2053-8855&rft.eissn=2053-8855&rft_id=info:doi/10.1093/omcr/omu061&rft_dat=%3Cpubmed_cross%3E25988066%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2631-e26070bf62a6d8ec822a7ecef486b60287d4e151cf1d514a68b155910fe47e583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/25988066&rfr_iscdi=true